Global Information
회사소개 | 문의 | 비교리스트

세계의 림프부종 치료 시장(2021-2027년) : 치료 종류별, 종류별, 이환 부위별, 연령층별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별 시장 규모 조사와 예측

Global Lymphedema Treatment Market Size study, by Treatment Type by Type by Affected Area by Age Group by Route of Administration by End User by Distribution Channel and Regional Forecasts 2021-2027

리서치사 Bizwit Research & Consulting LLP
발행일 2022년 01월 상품코드 1044601
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
가격
US $ 4,950 ₩ 6,307,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,963,000 Printable PDF (Enterprise License)


세계의 림프부종 치료 시장(2021-2027년) : 치료 종류별, 종류별, 이환 부위별, 연령층별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별 시장 규모 조사와 예측 Global Lymphedema Treatment Market Size study, by Treatment Type by Type by Affected Area by Age Group by Route of Administration by End User by Distribution Channel and Regional Forecasts 2021-2027
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 림프부종 치료 시장 규모는 2021-2027년 예측기간 중 건전한 성장률이 전망됩니다.

시장을 견인하는 주요 요인에는 세계적인 림프부종 환자수 증가, Drug Discovery를 위한 연구개발 투자 증가와 의료비 증가 등이 있습니다. 그러나 높은 수술 비용이 예측기간의 시장 성장을 저해하고 있습니다.

세계의 림프부종 치료(Lymphedema Treatment) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인·억제요인 분석, 시장 기회, COVID-19의 영향, 치료 종류별, 종류별, 이환 부위별, 연령층별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 림프부종 치료 시장 정의와 범위

제3장 세계의 림프부종 치료 시장 역학

  • 림프부종 치료 시장의 영향 분석(2019-2027년)

제4장 세계의 림프부종 치료 시장 업계 분석

  • Porter's 5 Force 모델
  • PEST 분석
  • 투자 채용 모델
  • 애널리스트의 추천사항과 결론
  • 주요 투자 기회
  • 주요 성공 전략

제5장 위험 평가 : COVID-19의 영향

    • 업계에 대한 COVID-19의 전체적인 영향 평가
    • COVID-19 이전 및 COVID-19 이후 시장 시나리오

제6장 치료 종류별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 압박요법
    • 수술
    • 약물요법
    • 레이저 치료
    • 기타

제7장 종류별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 원발성 림프부종
    • 이차성 림프부종

제8장 이환 부위별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 성기
    • 하지
    • 상지
    • 기타

제9장 연령층별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 성인
    • 고령자

제10장 투여 경로별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 경구
    • 주사
    • 기타

제11장 최종사용자별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 병원
    • 외래 수술 센터
    • 전문 진료소
    • 기타

제12장 유통 채널별, 세계의 림프부종 치료 시장

  • 시장 현황
  • 실적 : 잠재적 분석
  • 시장 규모 예측 : 2018-2027년
  • 하위 부문 분석
    • 직접 입찰
    • 약국
    • 기타

제13장 세계의 림프부종 치료 시장, 지역 분석

  • 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽의 현황
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 기타 유럽
  • 아시아태평양의 현황
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카의 현황
    • 브라질
    • 멕시코
  • 기타 지역

제14장 경쟁 정보

  • 주요 시장 전략
  • 기업 개요
    • Paul Hartmann AG
    • Convatec Inc.
    • SIGVARIS GROUP
    • Sanyleg Srl a socio unico
    • AIROS Medical, Inc.
    • Tactile Medical
    • BIOCOMPRESSION SYSTEMS
    • Lohmann & Rauscher GmbH & Co. KG
    • Mego Afek ltd.
    • ThermoTek, Cardinal Health

제15장 조사 과정

KSM 22.01.24

LIST OF TABLES

  • TABLE 1. Global Lymphedema Treatment market, report scope
  • TABLE 2. Global Lymphedema Treatment market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Lymphedema Treatment market estimates & forecasts by Treatment Type 2018-2027 (USD Billion)
  • TABLE 4. Global Lymphedema Treatment market estimates & forecasts by Type 2018-2027 (USD Billion)
  • TABLE 5. Global Lymphedema Treatment market estimates & forecasts by Affected Area 2018-2027 (USD Billion)
  • TABLE 6. Global Lymphedema Treatment market estimates & forecasts by Age Group 2018-2027 (USD Billion)
  • TABLE 7. Global Lymphedema Treatment market estimates & forecasts by Route of Administration 2018-2027 (USD Billion)
  • TABLE 8. Global Lymphedema Treatment market estimates & forecasts by End User 2018-2027 (USD Billion)
  • TABLE 9. Global Lymphedema Treatment market estimates & forecasts by Distribution Channel 2018-2027 (USD Billion)
  • TABLE 10. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. Global Lymphedema Treatment market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Global Lymphedema Treatment market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. U.S. Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. U.S. Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. U.S. Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. Canada Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. Canada Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. Canada Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. UK Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. UK Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. UK Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. Germany Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. Germany Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. Germany Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. RoE Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. RoE Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. RoE Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. China Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. China Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. China Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. India Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. India Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. India Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. Japan Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. Japan Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Japan Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. RoAPAC Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. RoAPAC Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. RoAPAC Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Brazil Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. Brazil Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. Brazil Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. Mexico Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. Mexico Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. Mexico Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. RoLA Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. RoLA Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. RoLA Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. Row Lymphedema Treatment market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 57. Row Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 58. Row Lymphedema Treatment market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 59. List of secondary sources, used in the study of global Lymphedema Treatment market
  • TABLE 60. List of primary sources, used in the study of global Lymphedema Treatment market
  • TABLE 61. Years considered for the study
  • TABLE 62. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Lymphedema Treatment market, research methodology
  • FIG 2. Global Lymphedema Treatment market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Lymphedema Treatment market, key trends 2020
  • FIG 5. Global Lymphedema Treatment market, growth prospects 2021-2027
  • FIG 6. Global Lymphedema Treatment market, porters 5 force model
  • FIG 7. Global Lymphedema Treatment market, pest analysis
  • FIG 8. Global Lymphedema Treatment market, value chain analysis
  • FIG 9. Global Lymphedema Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Lymphedema Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Lymphedema Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Lymphedema Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Lymphedema Treatment market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Lymphedema Treatment market, regional snapshot 2018 & 2027
  • FIG 15. North America Lymphedema Treatment market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Lymphedema Treatment market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Lymphedema Treatment market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Lymphedema Treatment market 2018 & 2027 (USD Billion)
  • FIG 19. Global Lymphedema Treatment market, company market share analysis (2020)

Global Lymphedema Treatment Market is valued approximately USD XXXX billion in 2020 and is anticipated to grow with a healthy growth rate of more than XXXX % over the forecast period 2021-2027. Lymphedema happens if the the lymph vessels is not able to adequately drain lymph fluid, it occurs commonly on arms and legs. The most common causes of lymphedema is Cancer. The treatment of the disease may include compression bandages, massage, compression stockings, sequential pneumatic pumping, careful skin care and, rarely, surgery to remove swollen tissue or to create new drainage routes. Increase in number of lymphedema cases globally is driving the growth for the market. For instance: according to NHS, about 200,000 suffer from lymphedema in U.K. annually. Also, increase in research and development investment for drug discovery and increasing health care expenditure is accelerating the market growth for lymphedema treatment. However, high costs of surgery impede the growth of the market over the forecast period of 2021-2027.

The key regions considered for the global Lymphedema Treatment market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is to dominate the market lymphedema treatment market in the forecasted period. As there is increase in prevalence of breast cancer in the region. For instance, according to the Lymphatic Education & Research Network, approximately 10 million Americans suffer from lymphedema and lymphatic diseases. Whereas, Asia-Pacific is anticipated to exhibit highest CAGR over the forecast period 2021-2027. Because there is increase in incidence of breast cancer and growing patient awareness of the lymphedema treatment.

Major market player included in this report are:

  • PAUL HARTMANN AG
  • Convatec Inc.
  • SIGVARIS GROUP
  • Sanyleg Srl a socio unico
  • AIROS Medical, Inc.
  • Tactile Medical
  • BIOCOMPRESSION SYSTEMS
  • Lohmann & Rauscher GmbH & Co. KG
  • Mego Afek ltd.
  • ThermoTek, Cardinal Health

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

  • Compression Therapy
  • Surgery
  • Drug Therapy
  • Laser Therapy
  • Others

By Type:

  • Primary Lymphedema
  • Secondary Lymphedema

By Affected Area:

  • Genital
  • Lower Extremity
  • Upper Extremity
  • Others

By Age Group:

  • Adult
  • Geriatric

By Route of Administration:

  • Oral
  • Injectable
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Speciality Clinics
  • Others

By Distribution Channel:

  • Direct Tender
  • Pharmacy Stores
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2018, 2019
  • Base year - 2020
  • Forecast period - 2021 to 2027

Target Audience of the Global Lymphedema Treatment Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors
  • Crash barrier systems
  • Lymphedema Treatment
  • Media Monitoring Tools
  • Automotive Connecting Rod Bearing

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Lymphedema Treatment Market, by Region, 2019-2027 (USD Billion)
    • 1.2.2. Lymphedema Treatment Market, by Treatment Type, 2019-2027 (USD Billion)
    • 1.2.3. Lymphedema Treatment Market, by Type, 2019-2027 (USD Billion)
    • 1.2.4. Lymphedema Treatment Market, by Affected Area, 2019-2027 (USD Billion)
    • 1.2.5. Lymphedema Treatment Market, by Age group, 2019-2027 (USD Billion)
    • 1.2.6. Lymphedema Treatment Market, by Route of Administration, 2019-2027 (USD Billion)
    • 1.2.7. Lymphedema Treatment Market, by End User, 2019-2027 (USD Billion)
    • 1.2.8. Lymphedema Treatment Market, by Distribution Channel, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Lymphedema Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Lymphedema Treatment Market Dynamics

  • 3.1. Lymphedema Treatment Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing cases of lymphedema diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of Surgery
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing R&D for drugs

Chapter 4. Global Lymphedema Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Lymphedema Treatment Market, by Treatment Type

  • 6.1. Market Snapshot
  • 6.2. Global Lymphedema Treatment Market by Treatment Type, Performance - Potential Analysis
  • 6.3. Global Lymphedema Treatment Market Estimates & Forecasts by Treatment Type 2018-2027 (USD Billion)
  • 6.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 6.4.1. Compression Therapy
    • 6.4.2. Surgery
    • 6.4.3. Drug Therapy
    • 6.4.4. Laser Therapy
    • 6.4.5. Others

Chapter 7. Global Lymphedema Treatment Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Lymphedema Treatment Market by Type, Performance - Potential Analysis
  • 7.3. Global Lymphedema Treatment Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
  • 7.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 7.4.1. Primary Lymphedema
    • 7.4.2. Secondary Lymphedema

Chapter 8. Global Lymphedema Treatment Market, by Affected Area

  • 8.1. Market Snapshot
  • 8.2. Global Lymphedema Treatment Market by Affected Area, Performance - Potential Analysis
  • 8.3. Global Lymphedema Treatment Market Estimates & Forecasts by Affected Area 2018-2027 (USD Billion)
  • 8.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 8.4.1. Genital
    • 8.4.2. Lower Extremity
    • 8.4.3. Upper Extremity
    • 8.4.4. Others

Chapter 9. Global Lymphedema Treatment Market, by Age Group

  • 9.1. Market Snapshot
  • 9.2. Global Lymphedema Treatment Market by Age Group, Performance - Potential Analysis
  • 9.3. Global Lymphedema Treatment Market Estimates & Forecasts by Age Group 2018-2027 (USD Billion)
  • 9.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 9.4.1. Adult
    • 9.4.2. Geriatric

Chapter 10. Global Lymphedema Treatment Market, by Route of Administration

  • 10.1. Market Snapshot
  • 10.2. Global Lymphedema Treatment Market by Route of Administration, Performance - Potential Analysis
  • 10.3. Global Lymphedema Treatment Market Estimates & Forecasts by Route of Administration 2018-2027 (USD Billion)
  • 10.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 10.4.1. Oral
    • 10.4.2. Injectable
    • 10.4.3. Others

Chapter 11. Global Lymphedema Treatment Market, by End User

  • 11.1. Market Snapshot
  • 11.2. Global Lymphedema Treatment Market by End User, Performance - Potential Analysis
  • 11.3. Global Lymphedema Treatment Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
  • 11.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 11.4.1. Hospitals
    • 11.4.2. Ambulatory Surgical Centers
    • 11.4.3. Speciality Clinics
    • 11.4.4. Others

Chapter 12. Global Lymphedema Treatment Market, by Distribution Channel

  • 12.1. Market Snapshot
  • 12.2. Global Lymphedema Treatment Market by Distribution Channel, Performance - Potential Analysis
  • 12.3. Global Lymphedema Treatment Market Estimates & Forecasts by Distribution Channel 2018-2027 (USD Billion)
  • 12.4. Lymphedema Treatment Market, Sub Segment Analysis
    • 12.4.1. Direct Tender
    • 12.4.2. Pharmacy Stores
    • 12.4.3. Others

Chapter 13. Global Lymphedema Treatment Market, Regional Analysis

  • 13.1. Lymphedema Treatment Market, Regional Market Snapshot
  • 13.2. North America Lymphedema Treatment Market
    • 13.2.1. U.S. Lymphedema Treatment Market
      • 13.2.1.1. Treatment Type breakdown estimates & forecasts, 2018-2027
      • 13.2.1.2. Type breakdown estimates & forecasts, 2018-2027
      • 13.2.1.3. Affected Area breakdown estimates & forecasts, 2018-2027
      • 13.2.1.4. Age Group breakdown estimates & forecasts, 2018-2027
      • 13.2.1.5. Route of Administration breakdown estimates & forecasts, 2018-2027
      • 13.2.1.6. End User breakdown estimates & forecasts, 2018-2027
      • 13.2.1.7. Distribution Channel breakdown estimates & forecasts, 2018-2027
    • 13.2.2. Canada Lymphedema Treatment Market
  • 13.3. Europe Lymphedema Treatment Market Snapshot
    • 13.3.1. U.K. Lymphedema Treatment Market
    • 13.3.2. Germany Lymphedema Treatment Market
    • 13.3.3. France Lymphedema Treatment Market
    • 13.3.4. Spain Lymphedema Treatment Market
    • 13.3.5. Italy Lymphedema Treatment Market
    • 13.3.6. Rest of Europe Lymphedema Treatment Market
  • 13.4. Asia-Pacific Lymphedema Treatment Market Snapshot
    • 13.4.1. China Lymphedema Treatment Market
    • 13.4.2. India Lymphedema Treatment Market
    • 13.4.3. Japan Lymphedema Treatment Market
    • 13.4.4. Australia Lymphedema Treatment Market
    • 13.4.5. South Korea Lymphedema Treatment Market
    • 13.4.6. Rest of Asia Pacific Lymphedema Treatment Market
  • 13.5. Latin America Lymphedema Treatment Market Snapshot
    • 13.5.1. Brazil Lymphedema Treatment Market
    • 13.5.2. Mexico Lymphedema Treatment Market
  • 13.6. Rest of The World Lymphedema Treatment Market

Chapter 14. Competitive Intelligence

  • 14.1. Top Market Strategies
  • 14.2. Company Profiles
    • 14.2.1. Paul Hartmann AG
      • 14.2.1.1. Key Information
      • 14.2.1.2. Overview
      • 14.2.1.3. Financial (Subject to Data Availability)
      • 14.2.1.4. Product Summary
      • 14.2.1.5. Recent Developments
    • 14.2.2. Convatec Inc.
    • 14.2.3. SIGVARIS GROUP
    • 14.2.4. Sanyleg Srl a socio unico
    • 14.2.5. AIROS Medical, Inc.
    • 14.2.6. Tactile Medical
    • 14.2.7. BIOCOMPRESSION SYSTEMS
    • 14.2.8. Lohmann & Rauscher GmbH & Co. KG
    • 14.2.9. Mego Afek ltd.
    • 14.2.10. ThermoTek, Cardinal Health

Chapter 15. Research Process

  • 15.1. Research Process
    • 15.1.1. Data Mining
    • 15.1.2. Analysis
    • 15.1.3. Market Estimation
    • 15.1.4. Validation
    • 15.1.5. Publishing
  • 15.2. Research Attributes
  • 15.3. Research Assumption
Back to Top
전화 문의
F A Q